Ralph Lauren Corporation · RL · FY2026 Q4 · Calendar Q2 2026
Ralph Lauren Crosses $8B Revenue as Q4 Beats Estimates on China Strength and AUR Expansion
Ralph Lauren's FY2026 Q4 results demonstrate sustained brand momentum, with full-year revenue surpassing $8 billion for the first time. The company beat EPS estimates by 9.8% and revenue estimates by 7.2%, driven by 16% AUR expansion and a 50%+ surge in China sales. Management maintained its FY2027 outlook for mid-single-digit revenue growth with operating-margin expansion, while acknowledging tariff and macro headwinds. The stock surged 13.9% on the report with 3.4x baseline volume and continued to drift 9.6% higher in the weeks following.
Company context
Snapshot as of publicationRalph Lauren Corporation is a prominent international entity primarily involved in the creation, marketing, and distribution of premium lifestyle goods across North America, Europe, Asia, and other global regions. The company's diverse product range includes: Apparel: A comprehensive selection of clothing for men, women, and children. Footwear & Accessories: Various shoe styles (casual, dress, boots, sneakers, sandals), eyewear, timepieces, both fashion and fine jewelry, scarves, hats, gloves, umbrellas, and an assortment of leather items like handbags, luggage, small leather goods, and belts. Home Goods: Linens for bed and bath, furniture, fabric and wall coverings, lighting solutions, tabletop items, kitchen textiles, floor coverings, and giftware. Fragrances: A variety of scents developed for both men and women.…
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Jul 21, 2026 |
| Raymond James | Outperform | Market Perform | Upgrade | Jul 21, 2026 |
| Telsey Advisory Group | Outperform | Outperform | Maintain | Jun 23, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | May 26, 2026 |
| UBS | Buy | Buy | Maintain | May 22, 2026 |
| BTIG | Buy | Buy | Maintain | May 22, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 22, 2026 |
| Needham | Buy | Buy | Maintain | May 21, 2026 |
| B of A Securities | Buy | Buy | Maintain | Apr 16, 2026 |
| Citigroup | Buy | Neutral | Upgrade | Mar 24, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 6, 2026 |
| Argus Research | Buy | Buy | Maintain | Jan 15, 2026 |
| TD Cowen | Buy | Buy | Maintain | Sep 30, 2025 |
| JP Morgan | Overweight | Overweight | Maintain | Sep 26, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | May 23, 2025 |
| BMO Capital | Underperform | Underperform | Maintain | May 23, 2025 |
| Guggenheim | Buy | Buy | Maintain | Feb 7, 2025 |
| Wedbush | Neutral | Neutral | Maintain | Aug 11, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 11, 2023 |
| OTR Global | Positive | Mixed | Upgrade | Apr 28, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 10, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 10, 2023 |
| Truist Securities | Buy | Buy | Maintain | Dec 16, 2021 |
| RBC Capital | Outperform | Sector Perform | Upgrade | Jan 15, 2021 |
| CFRA | Hold | Hold | Maintain | May 27, 2020 |
| PiperJaffray | Neutral | Neutral | Maintain | Nov 8, 2019 |
| Piper Sandler | Neutral | Neutral | Maintain | Nov 8, 2019 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Sep 24, 2019 |
| Bank of America | Underperform | Underperform | Maintain | Aug 26, 2019 |
| Nomura | Neutral | Neutral | Maintain | May 15, 2019 |
| Buckingham Research | Buy | Neutral | Upgrade | Jan 9, 2019 |
| Buckingham | Buy | Neutral | Upgrade | Jan 9, 2019 |
| Miller Tabak | Sell | Hold | Downgrade | Nov 20, 2017 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Nov 3, 2017 |
| Tigress Financial | Neutral | Neutral | Maintain | May 25, 2017 |
| CLSA | Buy | Buy | Maintain | Sep 28, 2016 |
| Macquarie | Outperform | Outperform | Maintain | Sep 27, 2016 |
| Brean Capital | Hold | Hold | Maintain | Aug 11, 2016 |
| Standpoint Research | Hold | Buy | Downgrade | Aug 8, 2016 |
| BB&T Capital | Buy | Buy | Maintain | May 20, 2016 |
| Susquehanna | Outperform | Positive | Maintain | Nov 3, 2015 |
| Stephens & Co. | Overweight | Equal Weight | Upgrade | Jul 13, 2015 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Jan 9, 2015 |
| Janney Capital | Neutral | Buy | Downgrade | Jan 9, 2015 |
| ISI Group | Strong Buy | Buy | Upgrade | Sep 9, 2014 |
| McNicoll Lewis Vlak | Buy | Buy | Maintain | May 12, 2014 |
| Maxim Group | Buy | Buy | Maintain | Apr 22, 2014 |
| Bank oferica | Neutral | Neutral | Maintain | Feb 10, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $385.91. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Analyst unavailable | $425 | $376.48 | +10.1% | Jul 21, 2026 |
| Raymond James | Analyst unavailable | $410 | $376.48 | +6.2% | Jul 21, 2026 |
| Telsey Advisory | Analyst unavailable | $460 | $407.84 | +19.2% | Jun 23, 2026 |
| Deutsche Bank | Analyst unavailable | $437 | $372.43 | +13.2% | May 22, 2026 |
| UBS | Jay Sole | $511 | $375.34 | +32.4% | May 22, 2026 |
| Wells Fargo | Analyst unavailable | $415 | $374.8 | +7.5% | May 22, 2026 |
| Barclays | Analyst unavailable | $439 | $374.8 | +13.8% | May 22, 2026 |
| Needham | Tom Nikic | $405 | $375.88 | +4.9% | May 21, 2026 |
| UBS | Analyst unavailable | $480 | $359.66 | +24.4% | May 5, 2026 |
| Evercore ISI | Analyst unavailable | $420 | $337.61 | +8.8% | Feb 6, 2026 |
| UBS | Analyst unavailable | $477 | $341.35 | +23.6% | Feb 6, 2026 |
| BTIG | Bob Drbul | $435 | $338.66 | +12.7% | Feb 6, 2026 |
| Barclays | Paul Kearney | $416 | $338.66 | +7.8% | Feb 6, 2026 |
| UBS | Analyst unavailable | $474 | $353.82 | +22.8% | Jan 28, 2026 |
| Deutsche Bank | Krisztina Katai | $422 | $366.18 | +9.4% | Jan 8, 2026 |
| UBS | Analyst unavailable | $473 | $360.94 | +22.6% | Jan 8, 2026 |
| Barclays | Analyst unavailable | $409 | $358.52 | +6.0% | Jan 6, 2026 |
| Telsey Advisory | Analyst unavailable | $435 | $366.61 | +12.7% | Dec 17, 2025 |
| Wells Fargo | Analyst unavailable | $400 | $371.66 | +3.7% | Dec 16, 2025 |
| Jefferies | Analyst unavailable | $425 | $367.5 | +10.1% | Dec 12, 2025 |
| Wells Fargo | Ike Boruchow | $385 | $355.89 | -0.2% | Dec 3, 2025 |
| Evercore ISI | Analyst unavailable | $375 | $319.66 | -2.8% | Nov 3, 2025 |
| Jefferies | Analyst unavailable | $385 | $338.47 | -0.2% | Oct 23, 2025 |
| UBS | Analyst unavailable | $421 | $332.12 | +9.1% | Oct 23, 2025 |
| BTIG | Analyst unavailable | $400 | $317.92 | +3.7% | Oct 14, 2025 |
| Barclays | Analyst unavailable | $352 | $317.23 | -8.8% | Oct 14, 2025 |
| Telsey Advisory | Dana Telsey | $350 | $306.12 | -9.3% | Sep 17, 2025 |
| Jefferies | Analyst unavailable | $365 | $306.12 | -5.4% | Sep 17, 2025 |
| Needham | Analyst unavailable | $335 | $299.24 | -13.2% | Aug 5, 2025 |
| Telsey Advisory | Analyst unavailable | $335 | $304.45 | -13.2% | Aug 4, 2025 |
| Wells Fargo | Ike Boruchow | $300 | $273.96 | -22.3% | May 23, 2025 |
| UBS | Jay Sole | $384 | $274.08 | -0.5% | May 23, 2025 |
| Wells Fargo | Ike Boruchow | $275 | $264.51 | -28.7% | May 14, 2025 |
| Barclays | Paul Kearney | $260 | $219.96 | -32.6% | Apr 28, 2025 |
| Goldman Sachs | Analyst unavailable | $262 | $209.59 | -32.1% | Apr 22, 2025 |
| UBS | Jay Sole | $315 | $237.34 | -18.4% | Jan 10, 2025 |
| Telsey Advisory | Dana Telsey | $247 | $219.02 | -36.0% | Nov 8, 2024 |
| Citigroup | Paul Lejuez | $189 | $203.03 | -51.0% | Oct 29, 2024 |
| Wells Fargo | Ike Boruchow | $205 | $199.19 | -46.9% | Oct 23, 2024 |
| CFRA | Zachary Warring | $171 | $203.24 | -55.7% | Oct 17, 2024 |
| Barclays | Paul Kearney | $200 | $159.39 | -48.2% | Aug 8, 2024 |
| Raymond James | Rick Patel | $195 | $171.46 | -49.5% | May 24, 2024 |
| Wells Fargo | Ike Boruchow | $180 | $169.57 | -53.4% | May 24, 2024 |
| CFRA | Zachary Warring | $160 | $169.57 | -58.5% | May 23, 2024 |
| BMO Capital | Simeon Siegel | $113 | $168.48 | -70.7% | May 23, 2024 |
| UBS | Jay Sole | $250 | $166.98 | -35.2% | May 16, 2024 |
| Jefferies | Ashley Helgans | $195 | $167.03 | -49.5% | Apr 30, 2024 |
| Goldman Sachs | Ralph Lauren | $132 | $138.39 | -65.8% | Dec 13, 2023 |
| J.P. Morgan | Matthew Boss | $141 | $128.49 | -63.5% | Aug 10, 2023 |
| Telsey Advisory | Dana Telsey | $155 | $132.78 | -59.8% | Aug 4, 2023 |
| Telsey Advisory | Dana Telsey | $140 | $117.71 | -63.7% | Feb 9, 2023 |
| Cowen & Co. | Cowen Cowen | $132 | $100.12 | -65.8% | Nov 17, 2022 |
| UBS | Jay Sole | $130 | $100.24 | -66.3% | Nov 11, 2022 |
| UBS | Jay Sole | $162 | $99.79 | -58.0% | Jun 13, 2022 |
| Credit Suisse | Michael Binetti | $130 | $93.24 | -66.3% | May 20, 2022 |
| Wells Fargo | Ike Boruchow | $110 | $105.61 | -71.5% | Apr 9, 2022 |
| Deutsche Bank | Gabriella Carbone | $136 | $117.95 | -64.8% | Feb 4, 2022 |
| Evercore ISI | Omar Saad | $160 | $117.95 | -58.5% | Feb 4, 2022 |
| Truist Financial | Beth Reed | $156 | $117 | -59.6% | Feb 3, 2022 |
| Cowen & Co. | John Kernan | $171 | $117 | -55.7% | Feb 3, 2022 |
| Goldman Sachs | Brooke Roach | $110 | $115.48 | -71.5% | Dec 14, 2021 |
| BMO Capital | Simeon Siegel | $110 | $121.48 | -71.5% | Nov 3, 2021 |
| Piper Sandler | Erinn Murphy | $102 | $118.24 | -73.6% | May 21, 2021 |
Track every rating change on RL the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session closeFollow RL with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Q4 revenue grew 12% year-over-year, with full-year revenue exceeding $8 billion for the first time in the company's history. EPS of $2.80 beat the $2.55 consensus by 9.8%, and revenue of $1.98 billion beat the $1.85 billion estimate by 7.2%. AUR increased 16% year-over-year, extending a multi-quarter streak of double-digit AUR gains that supported operating-margin expansion despite higher tariffs and labor costs. DTC channels added 1.4 million new customers. China sales surged over 50%, driving Asia regional growth near 30%. The stock rose 13.9% on the report with 3.4x baseline volume and drifted an additional 9.6% higher subsequently. Analyst consensus price target stands at $438 versus a current price of $385.91.
Guidance delta
Management maintained (rather than raised) its FY2027 outlook, calling for mid-single-digit revenue growth, operating-margin expansion, and marketing spend rising to approximately 8% of sales. This follows the prior quarter's raised FY2026 guidance, which projected high-single-digit to low-double-digit revenue growth. The maintained rather than raised outlook reflects normalization in wholesale growth and tariff/macro headwinds, but signals continued confidence in the brand's pricing power and DTC momentum. Notably, management cited a Supreme Court ruling lowering tariffs to 10% for most of FY27 as a tailwind, though caution remains about potential increases after the relief period ends.
Key takeaways
- Full-year revenue topped $8 billion for the first time, with Q4 revenue growing 12% year-over-year.
- AUR increased 16% in Q4, extending a streak of double-digit AUR gains that supported margin expansion despite tariff and labor cost pressures.
- China sales surged over 50% year-over-year, driving Asia regional growth near 30%.
- DTC growth added 1.4 million new customers alongside high-single-digit social-media follower gains.
- EPS of $2.80 beat estimates by 9.8%; revenue of $1.98 billion beat by 7.2%.
Management priorities
- Expand the Polo Blaze handbag line launching in fall to capture high-potential accessories demand.
- Open 108 new owned and partner stores this year across key-city ecosystems.
- Further invest in the Ask Ralph AI platform to enhance design and customer engagement.
- Continue Olympic, Wimbledon, and US Open brand activations tied to cultural and sporting moments.
- Celebrate 50-year anniversary in Japan and 60-year brand milestones to reinforce global brand equity.
Related earnings events
Consumer CyclicalSources
- Earnings call transcript and parsed analysis · 2026-05-21T17:22:32.101043+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-30T22:21:31.288801+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T22:21:31.286046+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.